Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP962738.RASUa7FkMNxewl8O-aGy038hGKodeBn_bS2S0Uj73puPI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP962738.RASUa7FkMNxewl8O-aGy038hGKodeBn_bS2S0Uj73puPI130_assertion type Assertion NP962738.RASUa7FkMNxewl8O-aGy038hGKodeBn_bS2S0Uj73puPI130_head.
- NP962738.RASUa7FkMNxewl8O-aGy038hGKodeBn_bS2S0Uj73puPI130_assertion description "[The serum CA125 concentrations were elevated in patients with ovarian cancer, advanced endometriosis with peritoneal or deep lesions, or ovarian endometriomas, but not in the patients with endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962738.RASUa7FkMNxewl8O-aGy038hGKodeBn_bS2S0Uj73puPI130_provenance.
- NP962738.RASUa7FkMNxewl8O-aGy038hGKodeBn_bS2S0Uj73puPI130_assertion evidence source_evidence_literature NP962738.RASUa7FkMNxewl8O-aGy038hGKodeBn_bS2S0Uj73puPI130_provenance.
- NP962738.RASUa7FkMNxewl8O-aGy038hGKodeBn_bS2S0Uj73puPI130_assertion SIO_000772 19337252 NP962738.RASUa7FkMNxewl8O-aGy038hGKodeBn_bS2S0Uj73puPI130_provenance.
- NP962738.RASUa7FkMNxewl8O-aGy038hGKodeBn_bS2S0Uj73puPI130_assertion wasDerivedFrom befree-20150227 NP962738.RASUa7FkMNxewl8O-aGy038hGKodeBn_bS2S0Uj73puPI130_provenance.
- NP962738.RASUa7FkMNxewl8O-aGy038hGKodeBn_bS2S0Uj73puPI130_assertion wasGeneratedBy ECO_0000203 NP962738.RASUa7FkMNxewl8O-aGy038hGKodeBn_bS2S0Uj73puPI130_provenance.